Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Chinese herbs and breast cancer

This article was originally published in The Tan Sheet

Executive Summary

Sixteen of 69 traditional Chinese botanical and zoological remedies "exhibited pronounced effects (>75% growth inhibition) on at least one" of five breast cancer cell lines, Michael Campbell, et al., University of California-San Francisco, report at AACR meeting. "Future studies with these crude aqueous extracts may lead to the isolation of novel active anti-tumor compounds," researchers note in poster abstract. Johns Hopkins University is studying use of Chinese herbals in breast and prostate cancer treatment (1"The Tan Sheet" Oct. 9, 2000, p. 15)

You may also be interested in...

Johns Hopkins Center Receives Five-Year, $8 Mil. NCCAM Grant

A new complementary medicine center at Johns Hopkins University initially will concentrate on alternative therapies for breast and prostate cancer.

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts